People: Dyax Corp (DYAX.O)

DYAX.O on Consolidated Issue listed on NASDAQ Global Market

21 Jul 2014
Price Change (% chg)

$-0.11 (-1.24%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Cohen, Ron 

Brief Biography

Dr. Ron Cohen, M.D., is an Independent Director of Dyax Corp., effective November 01, 2011. Dr. Cohen has been President and Chief Executive Officer of Acorda Therapeutics, Inc. since the company was founded in 1995. Dr. Cohen received his B.A. degree with honors in Psychology from Princeton University, and his M.D. from the Columbia College of Physicians & Surgeons and is Board Certified in Internal Medicine. Dr. Cohen previously was a Director and Chairman of the New York Biotechnology Association. He currently serves as a member of the Executive Committee and as Chairman Emeritus of the Emerging Company Section of the board of the Biotechnology Industry Organization (BIO). He also serves as a member of the Columbia-Presbyterian Health Sciences Advisory Council.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Henry Blair


Gustav Christensen


George Migausky


Andrew Ashe


Burt Adelman


Todd Bazemore

As Of 30 Dec 2013
Search Stocks